KLRA · Kailera Therapeutics, Inc.
$18.44
+0.69 (+3.89%)
At close · Aug 26
Market Cap
$2.30B
Shares
129.64M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$18.44
Open$17.71
Day$17.37–18.47
Available close range$16.54–26.00
Avg vol 30d560K
Short int6.1M · 4.7% float · 20.1d
Short vol34%
Last earningsAug 12, 2026
DataApr 2026–Aug 2026
Filing10-Q · Aug 12
The closing range uses available history since Apr 17, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.64
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−3%
below
RSI (14)
52
neutral
MACD trend
Positive
52-week position
20%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+98 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.68% of float · ▼ -8.5% MoM · 20.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — 13F breadth
Squeeze score
63
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−3%
Neutral
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
20%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+98 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.68% of float · ▼ -8.5% MoM · 20.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
98 holders — 13F breadth
Price context
position in its available closing range
Range low $17
Now $18 · 20%
Range high $26
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KLRA
this stock
Kailera Therapeutics, Inc.
|
$2.30B | — | — | — | 4.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.72B | +20.7% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +5.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$63.81B | +24.5% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.07B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KLRA | +0.7% | +9.2% | — | +8.9% | — |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | +1.1% | +4.2% | — | +6.3% | — |
Key facts
CIK
2096997
CUSIP
482931102
13F (30d)
96 filings
94 filers
Visit website
Investor relations